Two-stage virtual screening + 100 ns MD identifying nilotinib and alectinib as complementary BRAF V600E repurposing candidates for Langerhans cell histiocytosis
reproducible-research molecular-dynamics computational-biology openmm computational-chemistry drug-repurposing amber virtual-screening lch mmpbsa autodock-vina braf mm-gbsa braf-v600e langerhans-cell-histiocytosis kinase-inhibitor nilotinib alectinib
-
Updated
Apr 12, 2026 - Python